WJWoojin Jung

Woojin Jung

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Woojin Jung has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Long-term follow-up of vertebral compression fractures in inpatients treated with integrative Korean medicine: An observational study

    by Hyun A. Sim, Woojin Jung, Soo-Duk Kim, Hyunsuk Park, Jonghyun Lee, Hyeri Jo, Yeonsun Lee, In Heo, Byung-Kwan Seo, Woo-Chul Shin, et al.

    Conservative management is the recommended first-line treatment for thoracolumbar vertebral compression fractures (VCFs), with integrative Korean medicine (IKM) being widely used for treatment in Korea. However, evidence regarding long-term treatment outcomes is lacking. We aimed to investigate the effectiveness of IKM treatment for thoracolumbar VCFs. Data from inpatients with thoracolumbar VCFs who received IKM treatment, comprising acupuncture, pharmacopuncture, electroacupuncture, Chuna manual therapy, and herbal medicine, at 4 KM hospitals from April 1, 2016 to June 30, 2022 were analyzed; long-term follow-up was conducted. Outcome measures included the numeric rating scale for low back pain, Oswestry Disability Index, and EuroQol 5-dimension 5-level scores. Primary and secondary outcomes were evaluated using a linear mixed model. Logistic regression analysis was used to analyze factors associated with patient satisfaction. Overall, 166 patients with VCFs (mean age: 63.28 ± 12.64 years, women: 124 [74.7%]) were analyzed. The numeric rating scale score for low back pain decreased from 5.75 (95% confidence interval [CI] 5.53–5.96) at admission to 3.36 (95% CI 3.08–3.64) at discharge and 3.90 (95% CI 3.62–4.18) at follow-up. The Oswestry Disability Index score declined from 48.92 (95% CI 46.02–51.82) to 35.95 (95% CI 33.04–38.86) and 27.67 (95% CI 24.86–30.47) at discharge and follow-up, respectively. At follow-up, the VCF operation rate was 6%, with 80% of participants reporting satisfaction with IKM treatment. IKM could be an effective treatment option for patients with VCFs. Large-scale, randomized controlled trials are required.

  • Open Access

    A Korean Medicine Study on Inflammatory Acne, Focusing on Acupuncture Treatment

    by Hyeri Jo, YeonSun Lee, Woojin Jung, Hyunsuk Park, Sorim Kim, Ga Yeong Yi, Hyorim Kim

    Hyeri Jo, YeonSun Lee, Woojin Jung, Hyunsuk Park, Sorim Kim, Ga Yeong Yi, Hyorim Kim. Journal of Acupuncture Research 2024;41:323-33. https://doi.org/10.13045/jar.24.0022

  • Open Access

    Integrative Korean Medicine Treatments for Traumatic Facial Palsy Following Mandibular Fracture: A Case Report and Literature Review

    by Hyunsuk Park, Sook-Hyun Lee, Yeonsun Lee, Dong Joo Choi, Jonghyun Lee, Hyeri Jo, Woojin Jung, Soo-Duk Kim, Hyun A. Sim, Yoon Jae Lee, et al.

    Prior studies exploring the effectiveness of traditional Korean medicine (TKM) treatment for facial palsy have mainly focused on Bell’s palsy, and there are few studies on the effectiveness of TKM treatments for traumatic facial palsy following mandibular fracture. The patient was a 24-year-old Korean man with left-sided facial paralysis following a left mandibular fracture. Surgery was performed for the fracture and the facial palsy was treated using conventional medicine (CM) treatments for approximately 3 months, but there was no improvement observed in the patient’s condition. Subsequently, the patient underwent an integrative Korean medicine treatment regimen consisting of acupuncture, pharmacopuncture, cupping, moxibustion, and herbal medication for a duration of 2 months. After 2 months of treatments, the House–Brackmann facial grading scale changed from Ⅴ to II and Yanagihara’s unweighted grading score increased from 9 to 34. This case presentation and previous studies of traumatic facial palsy using TKM treatment show that TKM treatment may be considered a complementary or alternative treatment method to CM treatment in patients with traumatic facial palsy. PROSPERO registration number: CRD42023445051.